Abstract:Highlights • VGLUT1 and VGLUT2 are generally preserved in AD across the medial temporal lobe. • We report a lower density of VGLUT1 in the dentate gyrus stratum moleculare in AD. • VGLUT2 expression is lower in the AD subiculum and superior temporal gyrus. • VGLUT1 and VGLUT2 expression show a brain region-specific vulnerability in AD. Alzheimer's disease (AD) is a progressive neurodegenerative disorder for which there are very limited treatment options. Dysfunction of the excitatory neurotransmitter system is thought to play a major role in the pathogenesis of this condition. Vesicular glutamate transporters (VGLUTs) are key to controlling the quantal release of glutamate. Thus, expressional changes in disease can have implications for aberrant neuronal activity, raising the possibility of a therapeutic target. There is no information regarding the expression of VGLUTs in the human medial temporal lobe in AD, one of the earliest and most severely affected brain regions. This study aimed to quantify and compare the layer-specific expression of VGLUT1 and VGLUT2 between control and AD cases in the hippocampus, subiculum, entorhinal cortex, and superior temporal gyrus. Free-floating fluorescent immunohistochemistry was used to label VGLUT1 and VGLUT2 in the hippocampus, subiculum, entorhinal cortex, and superior temporal gyrus. Sections were imaged using laser-scanning confocal microscopy and transporter densitometric analysis was performed. VGLUT1 density was not significantly different in AD tissue, except lower staining density observed in the dentate gyrus stratum moleculare (p=0.0051). VGLUT2 expression was not altered in the hippocampus and entorhinal cortex of AD cases but was significantly lower in the subiculum (p=0.015) and superior temporal gyrus (p=0.0023). This study indicates a regionally specific vulnerability of VGLUT1 and VGLUT2 expression in the medial temporal lobe and superior temporal gyrus in AD. However, the causes and functional consequences of these disturbances need to be further explored to assess VGLUT1 and VGLUT2 as viable therapeutic targets.

Expression of VGLUTs contributes to degeneration and acquisition of learning and memory.

Glutaminase C Overexpression in the Brain Induces Learning Deficits, Synaptic Dysfunctions, and Neuroinflammation in Mice.

Age-related Spatial Cognitive Impairment is Correlated with Increase of Synaptotagmin 1 in Dorsal Hippocampus in SAMP8 Mice

Alzheimer's disease-associated region-specific decrease of vesicular glutamate transporter immunoreactivity in the medial temporal lobe and superior temporal gyrus

Increased hippocampal excitability and impaired spatial memory function in mice lacking VGLUT2 selectively in neurons defined by tyrosine hydroxylase promoter activity

Role of GLR-1 in Age-Dependent Short-Term Memory Decline

Variable alternative spliced exon (VASE)-containing and VASE-lacking neural cell adhesion molecule in the dorsal and ventral hippocampus of SAMP8 mice.

Blue native/SDS-PAGE combined with iTRAQ analysis reveals advanced glycation end-product-induced changes of synaptosome proteins in C57 BL/6 mice

Analysis of Neuronal Nitric Oxide Synthase Expression and Increasing Astrogliosis in the Brain of Senescence-Accelerated-Prone 8 Mice

mGluR-dependent plasticity in rodent models of Alzheimer's disease

Group 1 metabotropic glutamate receptor function and its regulation of learning and memory in the aging brain

Impairments in Endogenous AMPA Receptor Dynamics Correlates with Learning Deficits in Alzheimer's Disease Model Mice.

A minor impact of VGLUT1 expression level on quantal size revealed through the characterization of VGLUT1mEos2 knock-down new mouse model

Age-related spatial cognitive impairment is correlated with a decrease in ChAT in the cerebral cortex, hippocampus and forebrain of SAMP8 mice.

Research on age-related characteristics of senescence accelerated mouse SAMP8

GLS1 Mutant Mice Display Moderate Alterations of Hippocampal Glutamatergic Neurotransmission Associated with Specific Adaptive Behavioral Changes

The Hippocampal Proteomic Analysis of Senescence-Accelerated Mouse: Implications of Uchl3 and Mitofilin in Cognitive Disorder and Mitochondria Dysfunction in SAMP8

Transcriptomic responses in mouse brain exposed to chronic excess of the neurotransmitter glutamate

Memory Decline and Behavioral Inflexibility in Aged Mice Are Correlated With Dysregulation of Protein Synthesis Capacity

Utilizing an Animal Model to Identify Brain Neurodegeneration-Related Biomarkers in Aging

Age-Dependent Shift of AMPA Receptors From Synapses to Intracellular Compartments in Alzheimer's Disease: Immunocytochemical Analysis of the CA1 Hippocampal Region in APP/PS1 Transgenic Mouse Model